These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 2719011)

  • 1. Poor outcome from peritoneovenous shunts for refractory ascites.
    Scholz DG; Nagorney DM; Lindor KD
    Am J Gastroenterol; 1989 May; 84(5):540-3. PubMed ID: 2719011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritoneovenous shunts--devices of last resort.
    Shepherd KE; Miller BJ
    Can J Surg; 1988 Nov; 31(6):444-7. PubMed ID: 3179855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites.
    Ginès P; Arroyo V; Vargas V; Planas R; Casafont F; Panés J; Hoyos M; Viladomiu L; Rimola A; Morillas R
    N Engl J Med; 1991 Sep; 325(12):829-35. PubMed ID: 1875966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritoneovenous shunts: predictive factors of early treatment failure.
    Gleysteen JJ; Klamer TW
    Am J Gastroenterol; 1984 Aug; 79(8):654-8. PubMed ID: 6465113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient selection and survival after peritoneovenous shunting for nonmalignant ascites.
    Smith RE; Nostrant TT; Eckhauser FE; Wilson JP; Knol JA; Strodel WE
    Am J Gastroenterol; 1984 Aug; 79(8):659-62. PubMed ID: 6465114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis assessment of cirrhotic patients with refractory ascites treated with a peritoneovenous shunt.
    Guardiola J; Xiol X; Escribá JM; Castellví JM; Castellote J; Baliellas C; Rafecas A; Casais LA
    Am J Gastroenterol; 1995 Dec; 90(12):2097-102. PubMed ID: 8540495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The peritoneovenous shunt: expectations and reality.
    Moskovitz M
    Am J Gastroenterol; 1990 Aug; 85(8):917-29. PubMed ID: 2197858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneovenous shunt insertion for intractable ascites: a district general hospital experience.
    Hussain FF; Meer ZF; Lopez AJ
    Cardiovasc Intervent Radiol; 2004; 27(4):325-8. PubMed ID: 15346206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritoneovenous shunting for cirrhotic versus malignant ascites.
    Kostroff KM; Ross DW; Davis JM
    Surg Gynecol Obstet; 1985 Sep; 161(3):204-8. PubMed ID: 2412302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saphenoperitoneal shunts for patients with intractable ascites associated with chronic liver disease.
    Vadeyar HJ; Doran JD; Charnley R; Ryder SD
    Br J Surg; 1999 Jul; 86(7):882-5. PubMed ID: 10417558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneovenous shunting for intractable ascites.
    Gullstrand P; Alwmark A; Börjesson B; Joelsson B; Bengmark S
    Scand J Gastroenterol; 1982 Nov; 17(8):1009-12. PubMed ID: 7167735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of mortality and stenosis after transjugular intrahepatic portosystemic shunt.
    Russo MW; Jacques PF; Mauro M; Odell P; Brown RS
    Liver Transpl; 2002 Mar; 8(3):271-7. PubMed ID: 11910573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of LeVeen shunting in refractory ascites--a view from the other side.
    Grischkan DM; Cooperman AM; Hermann RE; Carey WD; Ferguson DR; Cook SA
    Surgery; 1981 Mar; 89(3):304-8. PubMed ID: 7466618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneovenous shunts in patients with intractable ascites: palliation at what price?
    Zervos EE; McCormick J; Goode SE; Rosemurgy AS
    Am Surg; 1997 Feb; 63(2):157-62. PubMed ID: 9012430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Palliative treatment of carcinomatous ascites with peritoneovenous shunt].
    Castellví Suaña JM; Baliellas Comellas C; Fabregat Prous J; Torras Torra J; Guardiola Capón J; Sánchez Gili M
    Rev Esp Enferm Dig; 1992 Nov; 82(5):331-3. PubMed ID: 1485985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short- and long-term effectiveness, morbidity, and mortality of peritoneovenous shunt inserted to treat massive refractory ascites of nephrogenic origin analysis of 14 cases.
    Holm A; Rutsky EA; Aldrete JS
    Am Surg; 1989 Nov; 55(11):645-52. PubMed ID: 2479308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritoneovenous shunting for intractable ascites.
    Tyden G; Samnegård H; Thulin L
    Acta Chir Scand; 1982; 148(7):597-600. PubMed ID: 7168289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgical treatment of ascites with Le Veen shunt in patients with alcoholic liver disease].
    D'Albuquerque LA; de Oliveira e Silva A; Genzini T; de Miranda MP; dos Santos TE; Roldan-Molina F; Gama-Rodrigues J
    Arq Gastroenterol; 1990; 27(3):126-31. PubMed ID: 2099140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [12-year experience with continuous peritoneovenous shunt in the treatment of therapy-resistant ascites and hepatorenal failure: benefits and pitfalls].
    Kreuzer W
    Wien Klin Wochenschr; 1989 Jan; 101(2):87-91. PubMed ID: 2916345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.